Most of the weight lost with effective incretin therapy is fat, but patients still need a plan to preserve strength, function, and nutritional adequacy
Diabetes Obes Metab (2021) 23:11624
A provider may review medical history, medications, weight-loss history, blood sugar markers, cardiovascular risk, gallbladder history, digestive symptoms, kidney or liver concerns, and nutrition status
Our team is here to support you every step of the way, helping you achieve your health and wellness goals with the latest, most effective treatments available.
You can read the full article at The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity A study investigated the effects of once-weekly subcutaneous (s.c.) semaglutide 2.4 mg on gastric emptying, appetite, and energy intake in people with obesity
Current labeling for all GLP-1 RAs includes a warning to consider reducing the sulfonylurea dose when initiating combination therapy
